Stefania Leoni

Sassari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis.

Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 08, 2025

Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia.

Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia.

Journal: Multiple sclerosis and related disorders

Published: November 08, 2023

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.

Journal: Journal of neurology

Published: April 19, 2023

Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study.

Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study.

Journal: Multiple sclerosis and related disorders

Published: September 27, 2022

Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.

Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.

Journal: Journal of neuroimmunology

Published: May 11, 2021

Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study).

Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study).

Journal: Multiple sclerosis and related disorders

Published: August 20, 2019

Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.

Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.

Journal: Neurology

Published: February 26, 2019

JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.

JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.

Journal: Journal of neurovirology

Published: July 08, 2016

Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.

Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.

Journal: PloS one

Published: January 21, 2016

Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.

Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.

Journal: Journal of the neurological sciences

Published: April 10, 2015

Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study.

Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study.

Journal: Journal of neurology

Published: December 02, 2014

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 24, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026